Key Takeaways The Biden administration proposed a new policy Tuesday that would allow Medicare and Medicaid to cover ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
Since 2018, Ozempic's net price has fallen from $531 to $290, or 45%. Since 2020, Rybelsus' net price has dropped from $376 to $296, or 21%. In contrast, Wegovy's net price has increased 21% since ...
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.